Product News
Avacta Group and Tufts University Collaborate to Develop Novel Drug Conjugate
Drug conjugate combines Avacta’s Affimer technology with conjugates developed at Tufts for precision delivery
Drug conjugate combines Avacta’s Affimer technology with conjugates developed at Tufts for precision delivery
Mission Bio closes Series A funding and launches Tapestri™ to accelerate the discovery, development and delivery of precision medicine
The unique story of Phenomenex CEO, Fasha Mahjoor
Affordable protein analysis platform with increased sensitivity and reproducibility
Study aims for early detection of pancreatic cancer using blood-based IMMray PanCan-d test
Offering advanced, affordable and simple DNA imaging